These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 3129281)

  • 21. Melatonin reduces the production and secretion of prolactin and growth hormone from rat pituitary cells in culture.
    Griffiths D; Bjøro T; Gautvik K; Haug E
    Acta Physiol Scand; 1987 Sep; 131(1):43-9. PubMed ID: 2823532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
    Sanyal S; Van Tol HH
    Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of long term hormonal cell cultures from the MtT/w15 prolactin- and growth hormone-secreting rat pituitary tumor.
    McKeel DW; Hajek SA
    Endocrinology; 1981 Apr; 108(4):1571-86. PubMed ID: 7472284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
    Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of rat-mouse somatic cell hybrids secreting growth hormone and prolactin.
    Melmed S; Fagin JA
    Exp Cell Res; 1986 Feb; 162(2):475-85. PubMed ID: 3510881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells.
    Burris TP; Freeman ME
    Proc Soc Exp Biol Med; 1994 Mar; 205(3):226-35. PubMed ID: 8171043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
    Trouillas J; Chevallier P; Remy C; Rajas F; Cohen R; Calle A; Hooghe-Peters EL; Rousset B
    Endocrinology; 1999 Jan; 140(1):13-21. PubMed ID: 9886801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
    Martinez de la Escalera G; Weiner RI
    Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective thyroliberin-induced prolactin synthesis and release in a hybrid GH strain.
    Brennessel BA; Biswas DK
    Mol Cell Biochem; 1984 Aug; 63(1):67-73. PubMed ID: 6092907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
    Enyeart JJ; Aizawa T; Hinkle PM
    Am J Physiol; 1985 May; 248(5 Pt 1):C510-9. PubMed ID: 3922229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of thyrotropin-releasing hormone and its metabolites, Cyclo(His-Pro) and TRH-OH, on growth hormone and prolactin synthesis in primary cultured pituitary cells of the common carp, Cyprinus carpio.
    Kagabu Y; Mishiba T; Okino T; Yanagisawa T
    Gen Comp Endocrinol; 1998 Sep; 111(3):395-403. PubMed ID: 9707485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in calcium requirements for forskolin-induced release of prolactin from normal pituitary cells and GH4C1 cells in culture.
    Delbeke D; Scammell JG; Dannies PS
    Endocrinology; 1984 Apr; 114(4):1433-40. PubMed ID: 6323146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
    Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor stimulates the prolactin synthesis and secretion in rat pituitary cells in culture (GH4C1 cells) by increasing the intracellular concentration of free calcium.
    Aanestad M; Røtnes JS; Torjesen PA; Haug E; Sand O; Bjøro T
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):361-6. PubMed ID: 8388615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.